NEURAMIS
1.1 mL, HA 20 mg/mL, Lidocaine 0.3%
Description
Neuramis is a monophasic cross-linked hyaluronic acid dermal filler at 20 mg/mL with 0.3% lidocaine, designed for general soft tissue augmentation in mid-dermal applications. Manufactured by Medytox (Korea), it uses proprietary SHAPE technology for uniform gel consistency, providing natural-feel lift for nasolabial folds, perioral lines, and marionette correction with integrated patient comfort.
Indication
Suitable for moderate folds and soft tissue contouring. Recommended for general dermal augmentation procedures where added patient comfort is desired.
Packaging
Supplied as a single 1.1 mL syringe containing HA at 20 mg/mL with 0.3% lidocaine.
Protocol
Inject into the mid-dermis using a 27–30G needle via retrograde linear threading or serial puncture; aspirate before each bolus. Deliver 0.1–0.3 mL per linear cm or per treatment point; typical session volume 1.0–2.0 mL for bilateral nasolabial correction. Massage gently post-injection. Longevity 9–12 months; reassess at 2 weeks.
Related Products
#25
REVOLAX DEEP PLUS
1.1 mL, HA 24 mg/mL, Lidocaine 0.3%
#6
REGENOVUE DEEP PLUS (CE)
1.1 mL x 1 Syr, lidocaine 0.3%, HA 24 mg/mL
#9
SOSUM M (CE) NO Lidocaine
1.1 mL x 2 Syr, HA 24 mg
#14
ELASTY DEEP PLUS
1.0 mL x 1 Syr, Lidocaine 0.3%